StreetInsider.com News Articles

Form SCHEDULE 13G/A TREACE MEDICAL CONCEPTS, Filed by: ARMISTICE CAPITAL, LLC

Fri, 14 Aug 2026 10:27:00 -0400

si-local-file:///var/storage/secattach/20260814/26926415.html

Form SCHEDULE 13G/A TREACE MEDICAL CONCEPTS, Filed by: ARMISTICE CAPITAL, LLC

Fri, 14 Aug 2026 10:27:00 -0400

si-local-file:///var/storage/secattach/20260814/26926415.html

Form 4 TREACE MEDICAL CONCEPTS, For: Aug 09 Filed by: Scanlan Sean F.

Wed, 12 Aug 2026 18:00:00 -0400

si-local-file:///var/storage/secattach/20260812/26914577.html

Form 4 TREACE MEDICAL CONCEPTS, For: Aug 09 Filed by: Scanlan Sean F.

Wed, 12 Aug 2026 18:00:00 -0400

si-local-file:///var/storage/secattach/20260812/26914577.html

Form SCHEDULE 13G/A TREACE MEDICAL CONCEPTS, Filed by: Treace John T.

Wed, 12 Aug 2026 17:32:00 -0400

si-local-file:///var/storage/secattach/20260812/26914459.html

Form SCHEDULE 13G/A TREACE MEDICAL CONCEPTS, Filed by: Treace John T.

Wed, 12 Aug 2026 17:32:00 -0400

si-local-file:///var/storage/secattach/20260812/26914459.html

Form 4 TREACE MEDICAL CONCEPTS, For: Aug 09 Filed by: Elder Scot Michael

Wed, 12 Aug 2026 17:30:00 -0400

si-local-file:///var/storage/secattach/20260812/26914439.html

Form 4 TREACE MEDICAL CONCEPTS, For: Aug 09 Filed by: Elder Scot Michael

Wed, 12 Aug 2026 17:30:00 -0400

si-local-file:///var/storage/secattach/20260812/26914439.html

Form 4 TREACE MEDICAL CONCEPTS, For: Aug 09 Filed by: Hair Mark

Wed, 12 Aug 2026 17:30:00 -0400

si-local-file:///var/storage/secattach/20260812/26914444.html

Form 4 TREACE MEDICAL CONCEPTS, For: Aug 09 Filed by: Hair Mark

Wed, 12 Aug 2026 17:30:00 -0400

si-local-file:///var/storage/secattach/20260812/26914444.html

Treace Medical Concepts Inc (TMCI) PT Raised to $5 at Truist Securities

Mon, 10 Aug 2026 07:23:05 -0400

Truist Securities analyst Richard Newitter raised the price target on Treace Medical Concepts Inc (NASDAQ: TMCI) to $5.00 (from $4.00) while maintaining a Hold rating.

Treace Medical Concepts, Inc. (TMCI) Tops Q2 EPS by 6c

Fri, 07 Aug 2026 07:31:45 -0400

Treace Medical Concepts, Inc. (NASDAQ: TMCI) reported Q2 EPS of ($0.24), $0.06 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $45.4 million versus the consensus estimate of $43.94 million.

For earnings history and earnings-related data on Treace Medical Concepts, Inc. (TMCI) click here.

Form 10-Q TREACE MEDICAL CONCEPTS, For: Jun 30

Fri, 07 Aug 2026 07:13:00 -0400

si-local-file:///var/storage/secattach/20260807/26887437.html

Form 10-Q TREACE MEDICAL CONCEPTS, For: Jun 30

Fri, 07 Aug 2026 07:13:00 -0400

si-local-file:///var/storage/secattach/20260807/26887437.html

Form 8-K TREACE MEDICAL CONCEPTS, For: Aug 07

Fri, 07 Aug 2026 07:10:00 -0400

si-local-file:///var/storage/secattach/20260807/26887432.html

Form 8-K TREACE MEDICAL CONCEPTS, For: Aug 07

Fri, 07 Aug 2026 07:10:00 -0400

si-local-file:///var/storage/secattach/20260807/26887432.html

Form SCHEDULE 13G/A TREACE MEDICAL CONCEPTS, Filed by: BlackRock, Inc.

Thu, 30 Jul 2026 11:20:00 -0400

si-local-file:///var/storage/secattach/20260730/26841287.html

Form SCHEDULE 13G/A TREACE MEDICAL CONCEPTS, Filed by: BlackRock, Inc.

Thu, 30 Jul 2026 11:20:00 -0400

si-local-file:///var/storage/secattach/20260730/26841287.html

Treace Medical Concepts Inc (TMCI) PT Raised to $4 at Truist Securities

Thu, 16 Jul 2026 07:10:24 -0400

Truist Securities analyst Richard Newitter raised the price target on Treace Medical Concepts Inc (NASDAQ: TMCI) to $4.00 (from $2.00) while maintaining a Hold rating.

Treace Medical completes first surgery with new HyperPlate XM implant

Thu, 18 Jun 2026 07:05:42 -0400

Treace Medical Concepts, Inc. (Nasdaq: TMCI) announced the completion of the first surgical case using its HyperPlate XM Dynamic Compression Locking Implant, a new addition to the company's foot and ankle product portfolio.

The implant combines FastPitch locking screws with titanium compression plates, and is designed for midfoot and hindfoot procedures including talonavicular, calcaneocuboid, naviculocuneiform, and tarsometatarsal fusion applications, as well as Evans calcaneal osteotomies. The system includes single-use sterile instruments, among them the GreatReleaseXM Rapid Release Instrument for joint preparation.

Paul Dayton, DPM, of the Foot & Ankle Center of Iowa in Des Moines, performed the first case, which involved a

Treace Medical completes first surgery with new HyperPlate XM implant

Thu, 18 Jun 2026 07:05:42 -0400

Paul Dayton, DPM, of the Foot & Ankle Center of Iowa in Des Moines, performed the first case, which involved a

Treace Announces First Surgical Case with the HyperPlate™ XM Dynamic Compression Locking Implant System

Thu, 18 Jun 2026 07:05:00 -0400

New portfolio addition to drive further penetration into incremental procedures throughout the foot and ankle; strengthens Treace’s comprehensive suite of technologies for its growing customer base

PONTE VEDRA, Fla., June 18, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (Nasdaq: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced the successful completion of the first case utilizing its HyperPlate™ XM Dynamic Compression Locking Implant.

HyperPlate™ fixation technology further advances the SpeedPlate® implant platform by incorporating FastPitch® locking screws into the

Treace Announces First Surgical Case with the HyperPlate™ XM Dynamic Compression Locking Implant System

Thu, 18 Jun 2026 07:05:00 -0400

HyperPlate™ fixation technology further advances the SpeedPlate® implant platform by incorporating FastPitch® locking screws into the

Form 4/A TREACE MEDICAL CONCEPTS, For: Jun 10 Filed by: Treace John T.

Fri, 12 Jun 2026 09:27:00 -0400

si-local-file:///var/storage/secattach/20260612/26638856.html

Form 4/A TREACE MEDICAL CONCEPTS, For: Jun 10 Filed by: Treace John T.

Fri, 12 Jun 2026 09:27:00 -0400

si-local-file:///var/storage/secattach/20260612/26638856.html